Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_assertion type Assertion NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_head.
- NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_assertion wasGeneratedBy ECO_0000203 NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_provenance.
- NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_assertion wasDerivedFrom befree-20140225 NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_provenance.
- NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_assertion SIO_000772 21220499 NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_provenance.
- NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_assertion evidence source_evidence_literature NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_provenance.
- NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_assertion description "[Sorafenib, a VEGFR inhibitor with activity against RAF kinase, is active against hepatocellular carcinoma (HCC); however, the possible involvement of sorafenib in the EMT remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832600.RAjXvWla9-CxQmMe5-cWkSINJ4qmvm29v0obdRUTyVZFo130_provenance.